Mark Ladanyi (MSKCC) #NGDx18 Clinical genomic profiling using the MSK-IMPACT large panel NGS assay to guide pt sele… https://t.co/GGV4fCBo6t

8:40am August 22nd 2018 via Twitter Web Client